ADMA Biologics (ADMA) Earnings Date, Estimates & Call Transcripts $17.80 +0.70 (+4.09%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$17.50 -0.30 (-1.69%) As of 07:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADMA Biologics Earnings Summary ADMA Biologics announced Q2 2025 earnings on August 6, 2025, reporting an EPS of $0.15, which topped the consensus estimate of $0.14 by $0.01. Quarterly revenue rose 13.8% year-over-year to $121.98 million, above analysts' expectations of $121.77 million. With a trailing EPS of $0.86 and a P/E Ratio of 20.70, ADMA Biologics' earnings are expected to grow 35.29% next year, from $0.51 to $0.69 per share. Upcoming Q3 Earnings DateNov. 6After Market ClosesEstimatedConsensus EPS (Aug. 6) $0.14 Actual EPS (Aug. 6) $0.15 Beat By $0.01 Actual Revenue (Aug. 6) $121.98MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)ADMA Upcoming EarningsADMA Biologics' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Powered by Get ADMA Biologics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ADMA Biologics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataADMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADMA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ADMA Biologics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251$0.20$0.20$0.20Q2 20251$0.21$0.21$0.21Q3 20251$0.22$0.22$0.22Q4 20251$0.24$0.24$0.24 ADMA Biologics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/6/2025Q2 2025$0.14$0.15+$0.01$0.14$121.77M$121.98M5/7/2025Q1 2025$0.16$0.14 -$0.02$0.11$116.40M$114.80M11/7/2024Q3 2024$0.13$0.15+$0.02$0.15$107.25M$119.84M8/8/2024Q2 2024$0.08$0.13+$0.05$0.13$86.44M$107.20M5/9/2024Q1 2024$0.05$0.08+$0.03$0.08$77.28M$81.90M2/28/2024Q4 2023$0.02$0.04+$0.02$0.16$73.50M$73.90M11/8/2023Q3 2023-$0.01-$0.01-$0.01$62.13M$67.30M ADMA Biologics Earnings - Frequently Asked Questions When is ADMA Biologics' earnings date? ADMA Biologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on ADMA's earnings history. What guidance has ADMA Biologics issued on next quarter's earnings? ADMA Biologics updated its FY 2025 earnings guidance on Thursday, August, 7th. The company issued revenue guidance of $500.0 million-$625.0 million, compared to the consensus revenue estimate of $507.7 million. Did ADMA Biologics beat their earnings estimates last quarter? In the previous quarter, ADMA Biologics (NASDAQ:ADMA) reported $0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $0.14 by $0.01. Learn more on analysts' earnings estimate vs. ADMA's actual earnings. How can I listen to ADMA Biologics' earnings conference call? The conference call for ADMA Biologics' latest earnings report can be listened to online. Listen to Conference Call How can I read ADMA Biologics' conference call transcript? The conference call transcript for ADMA Biologics' latest earnings report can be read online. Read Transcript How much revenue does ADMA Biologics generate each year? ADMA Biologics (NASDAQ:ADMA) has a recorded annual revenue of $426.45 million. How much profit does ADMA Biologics generate each year? ADMA Biologics (NASDAQ:ADMA) has a recorded net income of $197.67 million. ADMA has generated $0.86 earnings per share over the last four quarters. What is ADMA Biologics' price-to-earnings ratio? ADMA Biologics (NASDAQ:ADMA) has a trailing price-to-earnings ratio of 20.70 and a forward price-to-earnings ratio of 34.90. What is ADMA Biologics' EPS forecast for next year? ADMA Biologics' earnings are expected to grow from $0.51 per share to $0.69 per share in the next year, which is a 35.29% increase. More Earnings Resources from MarketBeat Related Companies ACAD Earnings Results AKRO Earnings Results ALLO Earnings Results FGEN Earnings Results GMAB Earnings Results VTRS Earnings Results RDY Earnings Results ASND Earnings Results MRNA Earnings Results QGEN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:ADMA) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access